Abstract
Objective
The aim of this study was to investigate the role of pre- operative neoadjuvant intra-arterial infusion chemotherapy (NAIC) in treating locally advanced cervical caner.
Methods
Nineteen locally advanced cervical cancer (LACC) patients from November 2003 to November 2005 were analyzed retrospectively. NAIC was administrated 2 courses every 2 weeks using a combination of 30 mg/m2 bleomycin and 50 mg/m2 cisplatin via bilateral femur arteries. The response to NAIC was assessed by pelvic examination and imaging diagnostics and histological analysis. Two weeks after NAIC radical hysterectomy with pelvic lymphadenectomy was performed.
Results
Radical hysterectomy with pelvic lymphadenectomy were performed in 18 patients successfully. The mean tumor reduction rate was 73.04%. The overall clinical response rate of NAIC was 84.2% with 2 complete responses and 16 partial responses. Only 1 nonresponder. Six of 7 cases who had parametrial infiltration had a absence after chemotherapy, no significant change was observed in 1 case who followed by radiotherapy. Multivariate logistic regression analysis indicated that tumor volume prior to treatment was determining factor affecting the efficacy of NAIC in LACC.
Conclusion
pre-operative NAIC inhibited the growth of LACC, minimized the size, eliminate effectively the pathologic risk factors in the pelvic cavity, to improve the operability in cervical cancer patients with stage IIB or above, considered inoperable.
Similar content being viewed by others
References
Rojas-Espaillat LA, Rose PG. Management of locally advanced cervical cancer. Curr Opin Oncol, 2005, 17: 485–492.
Gong X, Cai LP. New chemotheropy for cervical cancer. Acta Academiae Medicinae Jiangxi (China), 2004,44: 118–122
Yamakawa Y, Fujimura M, Hidaka T, et al. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer. Gynecol Oncol, 2000, 77: 264–270.
Chen MH, Wu YP, He K, et al. Study of neoadjuvant intraarterial infusion chemotherapy followed by surgery versus NAIC with preoperative radiotherapy followed by surgery in patients with stage Ib–IIIb cervical cancer. Maternal and Child Health Care of China (Chinese), 2006, 21: 613–617
Behtash N, Nazari Z, Ayatollahi H, et al. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer. Eur J Surg Oncol, 2006, 32: 1226–1230.
Li QS, Zhang XQ, Du XL, et al. Clinical study of neoadjuvant chemotherapy before operation in patients with cervical carcinoma. Chin J Prev Treat (Chinese), 2006, 13: 136–138.
Kobayashi K, Furukawa A, Takahashi M, et al. Neoadjuvant intra-arterial chemotherapy for locally advanced uterine cervical cancer: clinical efficacy and factors influencing response. Cardiovasc Intervent Radiol, 2003, 26: 234–241.
Duenas-Gonzalez A, Cetina L, Mariscal I, et al. Modern management of locally advanced cervical carcinoma. Cancer Treat Rev, 2003, 29: 389–399.
Motoyama S, Hamana S, Ku Y, et al. Neoadjuvant high-dose intra-arterial infusion chemotherapy under percutaneous pelvic perfusion with extracorporeal chemofiltration in patients with stages IIIa–IVa cervical cancer. Gynecol Oncol, 2004, 95: 576–82.
Maneo A, Chiari S, Bonazzi C, et al. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer. Gynecol Oncol, 2008, 111: 438–43.
deSouza NM, Soutter WP, Rustin G, et al. Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome. Br J Cancer, 2004, 90: 2326–2331.
Zhao EF, Song L, Wang MQ, et al. Clinical and pathological observations of neoadjuvant intraarterial chemotherapy for cervical cancer. Prog Obstet Gynecol (Chinese), 2006, 15: 42–46.
Cai HB, Chen HZ, Yin HH. Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer. J Obstet Gynaecol Res, 2006, 32: 315–323.
Choi YS, Sin JI, Kim JH, et al. Survival benefits of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy in locally advanced chemoresistant cervical cancer. J Korean Med Sci, 2006, 21: 683–689.
Meng QW, Shen GH, lv QB, et al. Evaluation intraaterial neoadjuvant chemotherapy in locally advanced carcinoma. J Med Res (Chinese), 2006, 35: 19–21.
Sugiyama T, Nishida T, Muraoka Y, et al. Radical surgery after neoadjuvant intra-arterial chemotherapy in stage IIIb squamous cell carcinoma of the cervix. Int Surg, 1999, 84: 67–73.
Selvaggi L, Loizzi V, DI Gilio AR, et al. Neoadjuvant chemotherapy in cervical cancer: a 67 patients experience. Int J Gynecol Cancer, 2006, 16: 631–637.
Termrungruanglert W, Tresukosol D, Vasuratna A, et al. Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2. Gynecol Oncol, 2005, 97: 576–581.
Panici PB, Greggi S, Scambia G, et al. High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: a preliminary report. Gynecol Oncol, 1991, 41: 212–216.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, Q., Zhang, Y. Neoadjuvant intra-arterial infusion chemotherapy followed by surgery in patients with locally advanced cervical cancer. Chin. -Ger. J. Clin. Oncol. 8, 537–540 (2009). https://doi.org/10.1007/s10330-009-0108-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-009-0108-5